JP2019500414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500414A5 JP2019500414A5 JP2018546742A JP2018546742A JP2019500414A5 JP 2019500414 A5 JP2019500414 A5 JP 2019500414A5 JP 2018546742 A JP2018546742 A JP 2018546742A JP 2018546742 A JP2018546742 A JP 2018546742A JP 2019500414 A5 JP2019500414 A5 JP 2019500414A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- amino acid
- seq
- acid substitutions
- fgf2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 229920001184 polypeptide Polymers 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 125000003275 alpha amino acid group Chemical group 0.000 description 12
- 102200031779 rs3204853 Human genes 0.000 description 10
- 238000006467 substitution reaction Methods 0.000 description 10
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 8
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 8
- 102220004441 rs121918684 Human genes 0.000 description 6
- 102220621903 N-acetylglucosamine-6-sulfatase_S94I_mutation Human genes 0.000 description 4
- 102200026930 rs80356671 Human genes 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101100281008 Homo sapiens FGF2 gene Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15196802.1 | 2015-11-27 | ||
| EP15196802 | 2015-11-27 | ||
| PCT/EP2016/073567 WO2017089016A1 (en) | 2015-11-27 | 2016-10-03 | Thermostable fgf2 polypeptide, use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019500414A JP2019500414A (ja) | 2019-01-10 |
| JP2019500414A5 true JP2019500414A5 (OSRAM) | 2019-12-05 |
| JP7131772B2 JP7131772B2 (ja) | 2022-09-06 |
Family
ID=54754475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018546742A Active JP7131772B2 (ja) | 2015-11-27 | 2016-10-03 | 熱安定性ｆｇｆ２ポリペプチド及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11746135B2 (OSRAM) |
| EP (1) | EP3380508B1 (OSRAM) |
| JP (1) | JP7131772B2 (OSRAM) |
| KR (1) | KR102650035B1 (OSRAM) |
| CN (1) | CN108779158A (OSRAM) |
| AU (1) | AU2016359722B2 (OSRAM) |
| BR (1) | BR112018010676A2 (OSRAM) |
| CA (1) | CA3006388C (OSRAM) |
| ES (1) | ES2824479T3 (OSRAM) |
| LT (1) | LT3380508T (OSRAM) |
| PL (1) | PL3380508T3 (OSRAM) |
| SG (1) | SG11201804402WA (OSRAM) |
| WO (1) | WO2017089016A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112190531B (zh) * | 2019-06-19 | 2022-11-01 | 湖北医药学院 | 抗细胞衰老制剂及其制备方法和应用、细胞及其构建方法 |
| CN115103903A (zh) * | 2019-09-19 | 2022-09-23 | 西北大学 | 用于人诱导型多能干细胞的具成本效益的培养基和操作方案 |
| CN114746436B (zh) * | 2019-11-25 | 2024-07-02 | 韩国海洋科学技术院 | 改善温度稳定性和蛋白酶抗性的fgf2多肽及其用途 |
| KR102428940B1 (ko) * | 2019-11-25 | 2022-08-03 | 한국해양과학기술원 | 온도안정성 및 단백질 분해효소 저항성을 향상시킨 fgf2 폴리펩타이드 및 그 용도 |
| CZ309550B6 (cs) * | 2021-06-15 | 2023-04-05 | Enantis s.r.o | Termostabilní polypeptid na bázi FGF18 a jeho použití |
| GB2616475A (en) * | 2022-03-11 | 2023-09-13 | Multus Biotechnology Ltd | Engineered fibroblast growth factor variants |
| EP4619418A1 (en) * | 2022-11-25 | 2025-09-24 | BTL Healthcare Technologies a.s. | The fgf-2 polypeptides with improved stability, the process for preparing the fgf-2 polypeptides and use thereof |
| CN116041478A (zh) * | 2022-12-19 | 2023-05-02 | 太东(镇江)生物科技有限公司 | 基于大肠杆菌体外纯化系统的人重组热稳定蛋白fgf2制备方法 |
| KR20240173282A (ko) * | 2023-06-02 | 2024-12-11 | (주)피앤피바이오팜 | 고안정성 활성지속형 염기성 섬유아세포 성장인자 변이체를 이용한 줄기세포 유래 엑소좀의 제조방법 |
| KR20240173283A (ko) * | 2023-06-02 | 2024-12-11 | (주)피앤피바이오팜 | 고안정성 활성지속형 염기성 섬유아세포 성장인자 변이체를 이용한 줄기세포의 배양방법 |
| WO2025141173A1 (en) | 2023-12-28 | 2025-07-03 | Meatable B.V. | Methods of increasing differentiation and/or fat accumulation in cells |
| WO2025186217A1 (en) | 2024-03-05 | 2025-09-12 | The Cultivated B. Gmbh | Animal collagen from non-animal sources |
| EP4613865A1 (en) | 2024-03-05 | 2025-09-10 | The Cultivated B. GmbH | Animal collagen from non-animal sources |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU614137B2 (en) | 1988-06-06 | 1991-08-22 | Takeda Chemical Industries Ltd. | Stabilized fgf composition and production thereof |
| US5202311A (en) | 1988-08-19 | 1993-04-13 | Children's Medical Center Corporation | Stabilized fgf composition |
| CA2020654A1 (en) | 1989-07-07 | 1991-01-08 | Yohko Akiyama | Stabilized fgf composition and production thereof |
| US5143829A (en) | 1990-03-29 | 1992-09-01 | California Biotechnology Inc. | High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| WO1995008630A1 (en) * | 1993-09-24 | 1995-03-30 | American Cyanamid Company | Surface loop structural analogues of fibroblast growth factors |
| WO1998037880A1 (en) * | 1997-02-26 | 1998-09-03 | Ciblex Corporation | Inhibitors of leaderless protein export |
| US7754686B2 (en) | 2000-08-31 | 2010-07-13 | Novartis Vaccines And Diagnostics, Inc. | Stabilized FGF formulations containing reducing agents |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| EP1444995A1 (en) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | FGF-2 derived proteins for the preparation of biomaterials or medical devices such as stents |
| US7816140B2 (en) * | 2005-06-14 | 2010-10-19 | The United States Of America As Represented By The Department Of Veterans Affairs | Composition and methods for osteogenic gene therapy |
| US20070212332A1 (en) * | 2005-08-11 | 2007-09-13 | Department Of Veterans Affairs | Methods for accelerating bone repair |
| CA2664921A1 (en) * | 2006-09-28 | 2008-04-03 | Hepacore Ltd. | N-terminal fgf variants having increased receptor selectivity and uses thereof |
| US7659379B1 (en) | 2007-05-24 | 2010-02-09 | Florida State University Research Foundation, Inc. | Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
| US8461111B2 (en) | 2009-05-20 | 2013-06-11 | Florida State University Research Foundation | Fibroblast growth factor mutants having improved functional half-life and methods of their use |
| EP2333074A1 (en) | 2009-12-14 | 2011-06-15 | Robert Steinfeld | Substances and methods for the treatment of lysosmal storage diseases |
| CA2802896C (en) | 2010-07-01 | 2021-05-11 | Regenerative Research Foundation | Methods for culturing undifferentiated cells using sustained release compositions |
| US9169309B2 (en) | 2011-03-01 | 2015-10-27 | Humanzyme Inc. | Thermostable variants of fibroblast growth factors |
| US9925270B2 (en) | 2011-11-28 | 2018-03-27 | The Regents Of The University Of California | bFGF-polymer conjugates, methods for making the same and applications thereof |
| WO2013090919A1 (en) * | 2011-12-16 | 2013-06-20 | Wisconsin Alumni Research Foundation | Fgf-2 having enhanced stability |
| US9023644B2 (en) | 2011-12-16 | 2015-05-05 | Wisconsin Alumni Research Foundation | FGF having enhanced stability |
| US9474785B2 (en) | 2012-06-07 | 2016-10-25 | New York University | Chimeric fibroblast growth factor 19 proteins and methods of use |
| EP2930181B1 (en) * | 2014-04-07 | 2017-10-11 | Miltenyi Biotec GmbH | Fibroblast growth factor muteins with increased activity |
-
2016
- 2016-10-03 LT LTEP16781318.7T patent/LT3380508T/lt unknown
- 2016-10-03 PL PL16781318T patent/PL3380508T3/pl unknown
- 2016-10-03 WO PCT/EP2016/073567 patent/WO2017089016A1/en not_active Ceased
- 2016-10-03 US US15/778,743 patent/US11746135B2/en active Active
- 2016-10-03 BR BR112018010676-3A patent/BR112018010676A2/pt active IP Right Grant
- 2016-10-03 AU AU2016359722A patent/AU2016359722B2/en active Active
- 2016-10-03 ES ES16781318T patent/ES2824479T3/es active Active
- 2016-10-03 JP JP2018546742A patent/JP7131772B2/ja active Active
- 2016-10-03 CN CN201680076784.3A patent/CN108779158A/zh active Pending
- 2016-10-03 KR KR1020187018035A patent/KR102650035B1/ko active Active
- 2016-10-03 CA CA3006388A patent/CA3006388C/en active Active
- 2016-10-03 SG SG11201804402WA patent/SG11201804402WA/en unknown
- 2016-10-03 EP EP16781318.7A patent/EP3380508B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019500414A5 (OSRAM) | ||
| JP2023082054A5 (OSRAM) | ||
| EP4467650A3 (en) | Scaffold proteins | |
| AR125394A2 (es) | Métodos y composiciones para la expresión génica en plantas | |
| JP2017018125A5 (OSRAM) | ||
| EA201991440A1 (ru) | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 | |
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| JP2018138049A5 (OSRAM) | ||
| JP2018510622A5 (OSRAM) | ||
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| JP2013530689A5 (OSRAM) | ||
| HRP20231496T1 (hr) | Cistein proteaza | |
| RU2013128896A (ru) | Сконструированные белки повторов, которые связываются с сывороточным альбумином | |
| NZ602351A (en) | Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
| JP2017524380A5 (ja) | 腫瘍血管遮断剤であるポリペプチド、遺伝子、発現ベクター、腫瘍血管遮断剤の組成物、及び腫瘍血管遮断剤であるポリペプチドの調製方法 | |
| JP2016519138A5 (OSRAM) | ||
| EA201791238A1 (ru) | Способы и композиции, в которых используются варианты полипептидов klotho | |
| JP2021505201A5 (OSRAM) | ||
| JP2017514522A5 (OSRAM) | ||
| EP1801206A4 (en) | PROCESS FOR THE PREPARATION OF L-ARGININE, L-ORNITHIN OR L-CITRULLINE | |
| MX2021004714A (es) | Proteina cas9 modificada, y uso de la misma. | |
| EP3141259A3 (en) | Repeat variable diresidues for targeting nucleotides | |
| MX2024013403A (es) | Variantes de gpr156 y usos de estas | |
| JP2018511344A5 (OSRAM) | ||
| NZ724196A (en) | Uti fusion proteins |